Art

J-GLOBAL ID：202002270270275906   Reference number：20A0346140

Phase II/III, randomized, double-blind, parallel-group study of monthly delayed-release versus daily immediate-release risedronate tablets in Japanese patients with involutional osteoporosis

退行期骨粗鬆症の日本人患者における毎月の遅延放出型対毎日の即時放出型リセドロナート錠剤の第二/第三相ランダム化,二重盲検,並行群研究

Author (9)： Soen Satoshi (Department of Orthopedic Surgery and Rheumatology, Kindai University Nara Hospital, Ikoma, Nara, Japan) ,  Kishimoto Hideaki (Department of Orthopedic Surgery, Nojima Hospital, Tottori, Japan) ,  Hagino Hiroshi (School of Health Science and Rehabilitation Division, Tottori University, Yonago, Tottori, Japan) ,  Sone Teruki (Department of Nuclear Medicine, Kawasaki Medical School, Kurashiki, Okayama, Japan) ,  Ohishi Hiroaki (EA Pharma Co., Ltd., Tokyo, Japan) ,  Fujimoto Tsukasa (Takeda Pharmaceutical Company Ltd., Osaka, Japan) ,  Sasaki Emma (Takeda Pharmaceutical Company Ltd., Osaka, Japan) ,  Tanaka Sakae (Orthopedic Surgery, Sensory and Motor System Medicine, Surgical Sciences, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan) ,  Sugimoto Toshitsugu (Internal Medicine 1, Shimane University, Faculty of Medicine, Izumo, Shimane, Japan)
Material： Journal of Bone and Mineral Metabolism  (JBMM)
Volume： 38  Issue： 1  Page： 86-98  Publication year： 2020 
JST Material Number： L0163A  ISSN： 0914-8779  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *osteoporosis ,...
Semi thesaurus term： *Involutional osteoporosis

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0346140&from=J-GLOBAL&jstjournalNo=L0163A") }}

Author keywords (5)： Osteoporosis ,  Risedronate ,  Delayed release ,  Immediate release ,  Japan

JST classification (4)： Drug therapy(=pharmacotherapy)for musculoskeletal diseases  (GG05020D) ,  Treatment for metabolic diseases,nutritional diseases.  (GD05030F) ,  Clinical application of other drugs  (GW23020V) ,  Clinical biopharmacy  (GY01022L)

Substance index (1)： Risedronate

Terms in the title (12)： 退行期骨粗鬆症 ,  日本人 ,  患者 ,  遅延放出 ,  放出 ,  リセドロナート ,  錠剤 ,  三相 ,  ランダム化 ,  二重盲検 ,  並行 ,  研究